Risk Factors for Failure of Splenic Angioembolization: A Multicenter Study of Level I Trauma Centers.


Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
01 2021
Historique:
received: 28 02 2020
revised: 02 07 2020
accepted: 19 07 2020
pubmed: 30 8 2020
medline: 8 1 2021
entrez: 30 8 2020
Statut: ppublish

Résumé

Angioembolization (AE) is an adjunct to nonoperative management (NOM) of splenic injuries. We hypothesize that failure of AE is associated with blood transfusion, grade of injury, and technique of AE. We performed a retrospective (2010-2017) multicenter study (nine Level I trauma centers) of adult trauma patients with splenic injuries who underwent splenic AE. Variables included patient physiology, injury grade, transfusion requirement, and embolization technique. The primary outcome was NOM failure requiring splenectomy. Secondary outcomes were mortality, complications, and length of stay. A total of 409 patients met inclusion criteria; only 33 patients (8%) required delayed splenectomy. Patients who failed received more blood in the first 24 h (P = 0.009) and more often received massive transfusion (P = 0.01). There was no difference in failure rates for grade of injury, contrast blush on computed tomography, and branch embolized. After logistic regression, transfusion in the first 24 h was independently associated with failure of NOM (P = 0.02). Patients who failed NOM had more complications (P = 0.002) and spent more days in the intensive care unit (P < 0.0001), on the ventilator (P = 0.0001), and in the hospital (P < 0.0001). Patients who failed NOM had a higher mortality (15% versus 3%, P = 0.007), and delayed splenectomy was independently associated with mortality (odds ratio, 4.2; 95% confidence interval, 1.2-14.7; P = 0.03). AE for splenic injury leads to effective NOM in 92% of patients. Transfusion in the first 24 h is independently associated with failure of NOM. Patients who required a delayed splenectomy suffered more complications and had higher hospital length of stay. Failure of NOM is independently associated with a fourfold increase in mortality.

Sections du résumé

BACKGROUND
Angioembolization (AE) is an adjunct to nonoperative management (NOM) of splenic injuries. We hypothesize that failure of AE is associated with blood transfusion, grade of injury, and technique of AE.
METHODS
We performed a retrospective (2010-2017) multicenter study (nine Level I trauma centers) of adult trauma patients with splenic injuries who underwent splenic AE. Variables included patient physiology, injury grade, transfusion requirement, and embolization technique. The primary outcome was NOM failure requiring splenectomy. Secondary outcomes were mortality, complications, and length of stay.
RESULTS
A total of 409 patients met inclusion criteria; only 33 patients (8%) required delayed splenectomy. Patients who failed received more blood in the first 24 h (P = 0.009) and more often received massive transfusion (P = 0.01). There was no difference in failure rates for grade of injury, contrast blush on computed tomography, and branch embolized. After logistic regression, transfusion in the first 24 h was independently associated with failure of NOM (P = 0.02). Patients who failed NOM had more complications (P = 0.002) and spent more days in the intensive care unit (P < 0.0001), on the ventilator (P = 0.0001), and in the hospital (P < 0.0001). Patients who failed NOM had a higher mortality (15% versus 3%, P = 0.007), and delayed splenectomy was independently associated with mortality (odds ratio, 4.2; 95% confidence interval, 1.2-14.7; P = 0.03).
CONCLUSIONS
AE for splenic injury leads to effective NOM in 92% of patients. Transfusion in the first 24 h is independently associated with failure of NOM. Patients who required a delayed splenectomy suffered more complications and had higher hospital length of stay. Failure of NOM is independently associated with a fourfold increase in mortality.

Identifiants

pubmed: 32861100
pii: S0022-4804(20)30519-9
doi: 10.1016/j.jss.2020.07.058
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

227-231

Investigateurs

Jason Murry (J)
Alan Tyroch (A)
Michael Foreman (M)
Adel Alhaj-Saleh (A)
Stephen Pan (S)
David Archer (D)
S Rob Todd (SR)
Lillian Kao (L)
Carlos Rodriguez (C)
Sharmila Dissanaike (S)

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Brittany Bankhead-Kendall (B)

Department of Surgery and Perioperative Care, Dell Seton Medical Center at the University of Texas at Austin, Austin, Texas. Electronic address: bbankhead-kendall@mgh.harvard.edu.

Pedro Teixeira (P)

Department of Surgery and Perioperative Care, Dell Seton Medical Center at the University of Texas at Austin, Austin, Texas.

Tashinga Musonza (T)

Baylor College of Medicine, Houston, Texas.

Tim Donahue (T)

University of Texas Health Science Center in Houston, Houston, Texas.

Justin Regner (J)

Texas A&M/Baylor Scott & White, Temple, Texas.

Kelly Harrell (K)

UNT Health Science Center, Fort Worth, Texas.

Carlos V R Brown (CVR)

Department of Surgery and Perioperative Care, Dell Seton Medical Center at the University of Texas at Austin, Austin, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH